AstraZeneca-Daiichi Sankyo Enhertu approved in China for breast cancer Ruchika Sharma25 Feb 2023 1:30 PM ISTUK: AstraZeneca and Daiichi Sankyo's Enhertu (trastuzumab deruxtecan) has been approved in China as a monotherapy for the treatment of adult...
AstraZeneca Calquence tablet formulation approved in EU for adults with chronic lymphocytic leukaemia Ruchika Sharma23 Feb 2023 11:30 AM ISTCalquence (acalabrutinib) is a next-generation, selective inhibitor of Bruton's tyrosine kinase (BTK).
AstraZeneca India gets CDSCO nod for Durvalumab to treat biliary tract cancer Ruchika Sharma17 Feb 2023 12:00 PM ISTNew Delhi: Science-led biopharmaceutical company, AstraZeneca India, has announced additional indication approval from Central Drugs...
AstraZeneca Forxiga approved in EU for treatment of symptomatic chronic heart failure Ruchika Sharma7 Feb 2023 4:15 PM ISTForxiga (dapagliflozin) is a first-in-class, oral, once-daily SGLT2 inhibitor.
AstraZeneca Tezspire approved for self administration in US with new pre filled pen Ruchika Sharma3 Feb 2023 12:15 PM ISTThe Tezspire pre-filled pen enables patients and caregivers to self-administer the medicine at home or in clinic via a simple process.
USFDA withdraws emergency use authorization for AstraZeneca COVID 19 treatment Evusheld Ruchika Sharma27 Jan 2023 4:42 PM ISTAstraZeneca said it was informed that the agency will decide about reinstating authorization of Evusheld if the prevalence of resistant variants in...
AstraZeneca concludes acquisition of Neogene Therapeutics Ruchika Sharma17 Jan 2023 1:15 PM ISTUK: AstraZeneca has completed the acquisition of Neogene Therapeutics Inc.. Neogene will operate as a wholly-owned subsidiary of AstraZeneca, with...
Asthma treatment: AstraZeneca Tezspire approved for self-administration in EU in new pre-filled pen Ruchika Sharma15 Jan 2023 9:00 AM ISTTezspire will be available as a fixed-dose 210mg subcutaneous injection via a pre-filled, single-use auto-injector (the Tezspire pre-filled pen), in...
AstraZeneca to acquire CinCor Pharma in USD 1.8 billion deal Ruchika Sharma9 Jan 2023 4:35 PM ISTWaltham: CinCor Pharma, Inc. today announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to...
USFDA accepts AstraZeneca’s BLA for Nirsevimab for prevention of RSV lower respiratory tract disease Ruchika Sharma7 Jan 2023 10:00 AM ISTRSV is a very contagious virus that can lead to serious respiratory illness, according to the Centers for Disease Control and Prevention.
AstraZeneca Calquence gets Japenese nod for treatment-naïve chronic lymphocytic leukaemia Ruchika Sharma1 Jan 2023 10:00 AM ISTCalquence (acalabrutinib) is a next-generation, selective inhibitor of BTK.
AstraZeneca gets Japanese approval for Imfinzi, Imjudo to treat 3 types of cancer Ruchika Sharma28 Dec 2022 11:30 AM ISTImfinzi (durvalumab) is a human monoclonal antibody that binds to the PD-L1 protein and blocks the interaction of PD-L1 with the PD-1 and CD80...
